Keywords: diab, ii, study, brazil, completed, biotech, holdings

DIAB II study in Brazil completed

Article | 23 September 1999

Print This

A study of Biotech Holdings' insulin receptor-sensitizer DIAB II intype 2 diabetics has been completed in Brazil and will form the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in